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Abstract
T-cells bearing the 𝛼𝛽TCR play a vital role in defending the host against foreign pathogens and
malignant transformation of self. Importantly, T-cells are required to remain tolerant to the host’s
own cells and tissues in order to prevent self-reactive responses that can lead to autoimmune dis-
ease. T-cells achieve the capacity for self/nonself discrimination by undergoing a highly selective
and rigorous developmental program during their maturation in the thymus. This organ is unique
in its ability to support a program of T-cell development that ensures the establishment of a func-
tionally diverse 𝛼𝛽TCR repertoire within the peripheral T-cell pool. The thymus achieves this by
virtue of specialized stromal microenvironments that contain heterogeneous cell types, whose
organization and function underpins their ability to educate, support, and screen different thymo-
cyte subsets through various stages of development. These stages range from the entry of early
T-cell progenitors into the thymus, through to the positive and negative selection of the 𝛼𝛽TCR
repertoire. The importance of the thymus medulla as a site for T-cell tolerance and the exit of
newly generated T-cells into the periphery is well established. In this review, we summarize cur-
rent knowledge on the developmental pathways that take place during 𝛼𝛽T-cell development in
the thymus. In addition, we focus on the mechanisms that regulate thymic egress and contribute
to the seeding of peripheral tissues with newly selected self-tolerant 𝛼𝛽T-cells.
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1 INTRODUCTION
The murine thymus appears during early stages of embryogenesis,
arising from the 3rd pharyngeal pouch (3PP) and initially consisting
of an endodermal-derived epithelial rudiment surrounded by neural
crest-derived mesenchyme.1,2 Development of the thymus is depen-
dent on the transcription factor Foxn1, which plays a key role in mul-
tiple aspects of thymic epithelial cell (TEC) regulation, including their
differentiation, proliferation, and formation of the 3-dimensional TEC
network characteristic of thymic parenchyma.3–5 The development of
many cell subtypes of the thymic microenvironment is dependent on
bidirectional signaling between stromal cells and developing thymo-
cytes. An example of this is the signaling between TECs and thymo-
Abbreviations: 3PP, 3rd pharyngeal pouch; Aire, autoimmune regulator; APECED, autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy; Cers2, ceramide synthase 2; CMJ,
corticomedullary junction; cTEC, cortical thymic epithelial cell; CTS, Cataract Shionogi; ETP, early T-cell progenitor; Fezf2, Fez family zinc-finger 2; Foxo1, Forkhead box protein O1; Klf2,
Krüpple-like factor 2; LPP3, lipid phosphate phosphatase 3; LT𝛽R, lymphotoxin beta receptor;M1, mature 1;M2, mature 2; mTEC, medullary thymic epithelial cell; Ptcd, peripheral T-cell
deficiency; PVS, perivascular space; RTE, recent thymic emigrant; S1P, sphingosine-1-phosphate; S1PR1, sphingosine-1-phosphate receptor 1; SGPL, S1P lyase; SM, semimature; SPHK,
sphingosine kinase; Spns2, spinster homolog 2; TEC, thymic epithelial cell; TRA, tissue-restricted antigen; T-reg, regulatory T-cell; TSP, thymus settling progenitor
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in anymedium, provided
the original work is properly cited.
c©2018 The Authors. Society for Leukocyte Biology Published byWiley Periodicals, Inc.
cytes often referred to as “cross-talk” whereby the development of
each population is interdependent on interactions with each other.
Intrathymic T-cell development occurs in a step-wise manner,
where immature thymocytes undergo progressive maturation within
thymic microenvironments (Fig. 1). Unlike the bone marrow, the
thymus does not contain a local pool of hematopoietic stem cells.
Consequently, T-cell development is dependent on the colonization
of the thymus by blood-borne progenitor cells that initially arise
from remote microenvironments.6 Hematopoietic progenitor entry
occurs in waves during both prenatal development and adulthood.
During fetal early stages, progenitors are mainly sourced from the
liver and enter the early thymic rudiment by migrating through the
surrounding mesenchyme layer and mainly give rise to multiple waves
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F IGURE 1 Pathways in intrathymic T-cell development. T-cell development in the thymus involves a complex series of stages that involve the
stepwise migration of developing thymocytes through cortical and medullary thymic microenvironments. At the corticomedullary junction (CMJ),
T-cell progenitors enter the thymus via blood vessels surrounded by pericytes, and develop into CD25−CD44+CD117+ early T-cell progenitors
(ETPs). In the cortex, ETPs progress through CD25/CD44 DN stages, which involves migration along a cellular matrix comprised of VCAM-1-
expressing cTEC. Cortex-resident DP thymocytes then express the 𝛼𝛽TCR, and undergo positive selection, when successful low affinity 𝛼𝛽TCR
interactions betweenDP thymocytes and cTECoccur. This generatesCD4+ andCD8+ SP thymocytes,whichmigrate to themedullawherenegative
selection takes place of those cells expressing TCRs that bind self-peptide-self-MHC complexes with high affinity. Following intrathymic selection,
SP thymocytes undergo final intrathymic maturation, acquire egress-competence and exit the thymus via blood vessels at the CMJ
of invariant 𝛾𝛿T-cells as well as 𝛼𝛽T-cells.3,7–10 In the postnatal and
adult, thymus 𝛼𝛽T-cell development dominates and progenitors
are sourced from the bone marrow and enter the thymus via blood
vessels at the corticomedullary junction (CMJ).9–11 Thus, although
the thymus produces T-cells throughout life, there are qualitative
differences in both the lymphoid progenitors that are recruited to
the thymus and the types of T-cell they generate. During steady-state
T-cell development in the adult mouse, the progenitor cell(s) that
represent thymus settling progenitors (TSPs) and undergo thymus
colonization remain poorly understood.12 This is likely at least in
part due to the very small number of these cells that exist within the
adult thymus, as well as the T-cell developmental capacity of multiple
bone marrow progenitors that can colonize the thymus in a variety of
experimental settings. However, downstream of TSP, intrathymic early
JAMES ET AL. 277
T-cell progenitors (ETPs) and their progeny have been well defined.
ETPs, identified by a CD4−CD8−CD25−CD44+CD117+ phenotype,
have multilineage potential, as T-cell lineage commitment does not
occur until progeny downstream of the ETPs.13 However in contrast
to the idea that thymus colonizing cells have multilineage potential,
the use of IL-7R𝛼cre fate mapping by Schlenner et al.14 showed
that the vast majority of thymocytes had developed from an Il7r
expressing pathway, suggesting a lymphoid bias in the progenitors that
enter the thymus. ETPs develop into CD4−CD8−CD25+CD44+ DN2
thymocytes and, following a period of proliferation, these cells down-
regulate CD44 andCD117, developing into CD4−CD8−CD25+CD44−
DN3 cells which have lost B-cell potential but still retain NK-cell,
dendritic cell (DC), and T-cell lineage potential.15–17 DN3 thymocytes
undergo TCR𝛽 rearrangement, and in-frame rearrangement of TCR𝛽
chains subsequently results in the expression of a pre-TCR complex
enabling DN3 thymocytes to undergo 𝛽-selection and progress to the
CD4+CD8+ DP stage, where TCR𝛼 rearrangements occur and allow
expression of the 𝛼𝛽TCR complex. CD4+CD8+ DP thymocytes reside
in the cortex, have a 3–4 day lifespan, and die by neglect in the absence
of 𝛼𝛽TCR signals.18 As TCR gene rearrangements occur randomly,
the 𝛼𝛽TCR repertoire is highly diverse and must be appropriately
screened for its ability to recognize self-peptide/self-MHC complexes.
The first step in this process is termed positive selection, a process
in which DP thymocytes expressing an 𝛼𝛽TCR that recognizes and
binds to self-peptide/self-MHC complexes presented by cortical TECs
(cTECs) above a minimum recognition threshold triggers their further
differentiation.19,20 Indeed, DP thymocytes are programmed for cell
death by default and it is the interaction between TCR and self-peptide
self-MHC complexes that induces TCR signaling that promotes sur-
vival and differentiation.21 Positive selection of DP thymocytes also
results in commitment and differentiation into either CD4+CD8− SP4
or CD4−CD8+ SP8 thymocytes, recognizing MHC Class II or Class I,
respectively.22 Exit from the cortex is determined by the upregulation
of CCR723,24 by positively selected thymocytes and expression of the
semaphorin 3E receptor PlexinD1.25 This enables newly selected cells
to migrate away from CCL25 expressing cortical microenvironments
toward the thymus medulla, a region rich in the CCR7-ligands CCL19
and CCL21 that are expressed by multiple stromal cells including
medullary thymic epithelium (mTEC). As such, the thymus medulla
acts as a repository for newly produced CD4+ and CD8+ thymocytes
capable of self-MHC recognition. Importantly, interactions between
these semimature (SM) thymocytes and their surrounding stromal
microenvironments ensure effective T-cell tolerance is achieved via
the removal of self-reactive thymocytes and Foxp3+ regulatory T-cell
development, as well as the regulated exit of mature self-tolerant
T-cells from the thymus.
2 THYMUS MEDULLA ORGANIZATION FOR
T-CELL TOLERANCE AND POSTSELECTION
MATURATION
Thymic microenvironments contain epithelial cells, and are orga-
nized into distinct cortex and the medulla areas. The developmental
transitions that thymocytes undergo are regulated by signals from the
microenvironments that they inhabit, with different signals and cell
types being present in distinct regions of the thymus. For example,
cTECs within the cortex of the thymus regulate the proliferation and
differentiation of DN and DP thymocytes through their production
of cytokines (e.g., IL-7), chemokines (e.g., CXCL12), and expression of
Notch ligands (e.g., DLL4).26–29
Similarly, within the thymic medulla, mTECs are specialized for spe-
cific stages of thymocyte development. For example, mTECs are essen-
tial regulators of tolerance induction via both negative selection and
Foxp3+ natural regulatory T-cell (nT-Reg) development. The impor-
tance ofmTEC for T-cell tolerance is highlighted inmice that lack orga-
nized medullary structures, including mTEC-deficient Relb−/− mice,
andmice lackingmembers of the TNFR superfamily (e.g., CD40, RANK,
LT𝛽R), all of which show signs of T-cell-mediated autoimmunity.30–34
Negative selection is thought to play a key role in establishing cen-
tral tolerance, and involves the clonal deletion of autoreactive T-cells
to limit their escape into peripheral tissues. The process of negative
selection occurs through apoptosis of thymocytes that bear high affin-
ity TCRs for self and therefore bind strongly to self-peptideMHC com-
plexes triggering strong TCR signals. In addition, lineage diversion of
CD4+ SP thymocytes, that involves expression of themaster transcrip-
tion factor Foxp3, results in the formation of nT-Reg that leave the
thymus and populate peripheral tissues to limit functional responses
of autoreactive T-cells that have escaped negative selection.35 mTECs
are highly specialized in their ability to enforce both thymic tolerance
mechanisms. This is at least in part through their ability to ectopically
express tissue-restricted antigens (TRAs). TRAs are self-proteins that
are usually restricted to functionally distinct cellswithin peripheral tis-
sues, however mTECs are able to ectopically generate such proteins
and present them as peptides to developing thymocytes. Two key reg-
ulators have been identified within mTECs to regulate the expression
of TRAs, the autoimmune regulator (Aire) and Fezf2. Aire is expressed
within a specific subpopulation of mTECs and has been shown to be
functionally important in both humans and mice, with human patients
that carry a genetic mutation of Aire suffering from autoimmune-
polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and
Aire-deficientmiceexhibiting a similar autoimmunedisorder.36–38 This
is due to the requirement for Aire for the deletion of specific self-
reactive clones of T-cells carrying TCRs specific to Aire-dependent
genes and the development of nT-Reg.38,39 However not all TRAs are
Aire dependent, as mTECs are able to express some TRAs indepen-
dently of Aire. mTECs express Fez family zinc-finger 2 (Fezf2), which
has been shown to promote promiscuous gene expression of Aire-
independent TRAs.40 Both Aire-deficient mice and mice lacking Fezf2
in TECs have been shown to exhibit autoimmune deficiencies, high-
lighting these regulators of TRAexpression as key regulators of central
tolerance induction.36–38,40 Although the expression of Fezf2 in mTEC
was thought to be regulated by lymphotoxin beta receptor (LT𝛽R)-
signaling, a known regulator of mTEC development, further analysis
of LT𝛽R-deficient mice revealed continued expression of both Fezf2
as well as Aire in mTEC.30,32,40,41 Interestingly, the RANK-RANKL sig-
naling axis initially shown to control the development of Aire+ mTEC
was recently found to additionally regulate development of Fezf2+
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mTEC, highlighting a common developmental signaling pathway in
the formation of medullary microenvironments essential for central
tolerance.32,34,42 Thus, the mTEC population as a whole expresses
a vast array of self-antigens, and their presentation either directly
or indirectly via cross-transfer to DC within the medulla effectively
screens the newly selected TCR repertoire for self-reactivity.
The ability of the thymic medulla to effectively support T-cell tol-
erance relies on the regulated colocalization of positively selected SP
thymocytes bearing the chemokine receptorCCR7, andmTECs secret-
ing the cognate CCR7 chemokine ligands CCL19 and CCL21. Of the
CCR7 ligands, it has recently been shown thatCCL21a is themajor reg-
ulator of CCR7-mediated SP thymocyte migration, and in its absence
there is a failure in thymic tolerance that leads to autoimmunity.43
Importantly, the thymus medulla is also rich in a heterogeneous mix-
tureofDCs,whichplayakey role inbothnegative selectionandFoxp3+
T-cell development. Interestingly, we recently showed that an explana-
tion for the breakdownof thymic tolerance in Ltbr−/−mice is the reduc-
tion in the size of the intrathymicDCpool rather than loss of organized
LT𝛽R-dependent mTEC, a finding that emphasizes the importance of
DC for thymic tolerance.32 Whether this control of thymic DC maps
to the ability of this receptor to regulate CCR7 ligand expression in
thymic stroma44 is not clear, although the survival of at least some
thymic DC is regulated via CCR7.45 In conclusion, the thymus medulla
represents an importantmicroenvironment for T-cell development for
several reasons. First, a period ofmedullary residency that follows pos-
itive selection in the cortex enables the thymus to impose central tol-
erance mechanisms on newly produced CD4+ and CD8+ thymocytes.
Second, during their time within the medulla, mature thymocytes pro-
gressively acquire “egress competence” through a program of postse-
lection maturation, which enables them to exit the thymus and enter
the periphery.
3 REGULATORS OF THYMUS EMIGRATION
Although several studies have examined the time SP thymocytes spend
within the thymus,46 most recent work indicates that a period of 4–
5 days of residency follows progression to the SP thymocyte stage.47
In linewith this period ofmedulla occupancy, SP thymocytes are devel-
opmentally heterogeneous. For example, early studies showed that
HSA expression levels could be used to sequentially define different
maturational stages within CD4+ SP thymocytes.48 HSAhi cells were
defined as “SM” cells still susceptible to tolerance induction, while
HSAlo cells were shown to be resistant to the induction of apoptosis
following TCR stimulation. Thus, changes in the maturational status
of the SP thymocytes can be revealed by their phenotypic properties.
More recently, SP thymocyte heterogeneity has further been revealed
using a variety of additional cell surface phenotypes, including the
chemokine receptors CCR4, CCR7, and CCR9. Using this approach to
analyze CD4+ SP thymocyte developmental heterogeneity, expression
of CCR4 and CCR9 was shown to identify newly generated cells, with
more mature cells having a CCR4−CCR7+CCR9− phenotype.49–51
Additional phenotypic markers used to separate SP thymocytes on the
basis of their developmental status include CD69, CD62L, and Qa2,
although the relevance of expression levels of the latter in relation
to maturational state has recently been questioned.47,52–54 Most
recently, Xing et al.52 redefined the progressive postselection matu-
ration stages that occur in the medulla by analyzing the expression of
CD69 and MHC Class I within SP4 and SP8 thymocytes. Importantly,
this studywas able to reveal 3 distinct populationswithin both SP4 and
SP8 thymocytes that were distinct in terms of their responsiveness to
TCR stimulation, as well as their thymus egress capabilities.52 Thus,
comparative analysis showed thatCD69+MHCClass I− SP thymocytes
were the least mature and hence these cells were termed SM. Next,
CD69+MHC Class I+ SP thymocytes were termed mature 1 (M1) and
shown to be proliferation-competent following TCR stimulation, while
CD69−MHC Class I+ cells were termed mature 2 (M2), which were
shown to demonstrate both TCR-induced proliferation and cytokine
secretion competency.52 Importantly, M2 cells were also shown to
express genes that control thymocyte egress, including the gene
encoding the sphingosine-1-phosphate receptor 1 (S1PR1), which has
been used as a marker of mature thymocytes in several studies.52,53,55
S1PR1 is a G protein-coupled cell surface receptor which in the
thymus mediates migration of S1PR1+ thymocytes toward a gradient
of the lipid signaling molecule sphingosine-1-phosphate (S1P).55 The
expression of several other important regulators including Forkhead
box protein O1 (Foxo1) and Krüpple-like factor 2 (Klf2) are also
upregulated during SP thymocyte maturation.56–58 Significantly,
CD62L and S1PR1 are both downstream targets of Klf2. Moreover,
the expression of S1PR1/CD69 expression is linked, whereby CD69
possesses the capacity to bind and inhibit S1PR1 via internalization
and degradation.59 Therefore, as SP thymocytesmature, they increase
Foxo1 and Klf2 expression, which in turn up-regulates CD62L as well
as S1PR1 expression at the same time as CD69 is down-regulated,
such regulated patterns of expression likely act to limit the timing
of thymic egress to mature thymocytes having undergone central
tolerance events.56–58,60
Through the careful examination of SP thymocyte heterogene-
ity described above, the process of thymocyte egress can be split
into 3 separate stages (Fig. 2). The first of these steps involves the
progressive maturation of medullary resident, postselection SP thy-
mocytes that reach an egress competent stage as defined by their
expression of S1PR1. This process enables S1PR1+ SP thymocytes to
migrate toward an S1P gradient at least in part formed by the com-
bined activity of pericytes and DCs surrounding blood vessels at the
CMJ. This initial step is followed by a second phase in which SP thy-
mocytes cross the basement membrane surrounding blood vessels to
enter into the perivascular space (PVS), the region defined as the space
between blood endothelial cells and surrounding pericytes. The final
step comprises reverse transendothelial migration, in which mature
SP thymocytes exit from the PVS and enter into the blood stream
by migrating across thymic blood endothelium, enabling them to join
the peripheral T-cell pool as recent thymic emigrants (RTE). Currently,
it is not fully understood how intrathymic microenvironments and
particular thymic stromal cells influence each of these phases of the
emigration process. Moreover, while the above findings suggest that
emigrationoccurs via anorderedand linear “conveyor belt”mechanism
in which only the most mature SP thymocytes are able to leave the
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F IGURE 2 Thymic T-cell egress. Following selection, SP thymocytes undergo maturation in the medulla where they develop from immature
HSAhiCD69+CD62L− to mature HSAloCD69−CD62L+ SP thymocytes. This maturation enables SP thymocytes to express the sphingosine-1-
phosphate (S1P) receptor 1 (S1PR1) and undergo thymus emigration. Mature thymocytes first migrate into the perivascular space (PVS) of blood
vessels at the corticomedullary junction (CMJ) the space between pericytes and endothelial cells of the blood vessel, and then undergo reverse
transendothelial migration into the blood
thymus, earlier studies indicated that thymocytes may also leave the
thymus as part of a “lucky dip” model.47,61 While further work is
required to examine stages in thymocyte egress and the factors that
regulate this process, in the remainder of this review we summarize
current knowledge on the known regulators of thymic exit.
4 THE S1P–S1PR1 AXIS
Perhaps the most well-characterized mechanism of thymus emigra-
tion from the adult thymus involves expression of S1PR1 by mature
thymocytes and the production of one of its ligands, S1P. Disruption
of this axis via multiple means perturbs thymic output resulting in
reduced T-cells in the periphery and an intrathymic accumulation of
mature thymocytes.55,62,63 Initial studies revealed the importance of
this pathway for thymic egress through the use of the immunomod-
ulator FTY720, a potent agonist of S1PR1, which prevents migration
to S1P by inducing down-regulation of the S1PR1. Thus, treatment of
mice with FTY720 led to an intrathymic accumulation of mature thy-
mocytes, and a reduction in peripheral T-cell numbers in secondary
lymphoid organs.64–69
As S1PR1 ligation can cause receptor down-regulation, intrathymic
levels of S1P must be kept tightly restricted, such that free S1P is only
available at functionally relevant levels in the close proximity of the
blood vessels that represent the points of thymic exit into the S1P-rich
blood circulatory system. In this setting, it is critical for tight regula-
tion of thymic emigration that S1P levels must remain sufficiently low
within the rest of the thymic parenchyma to enable the formation of
a suitable gradient for effective migration.70,71 Several mouse models
have revealed that within the thymus, multiple cell types regulate the
S1P–S1PR1 axis by acting to establish and maintain the intrathymic
S1P gradient. The mechanisms that regulate the S1P gradient within
thymic tissues are therefore tightly regulated by a fine balance existing
between the production andmaintenance of high S1P levels at the site
of exit, and regulation of low levels by degrading or dephosphorylating
S1Pwithin the surrounding thymic microenvironment.
4.1 Regulation of S1P levels
Maintaining high levels of S1P at the site of exit has primarily
been attributed to the production of S1P by thymic pericytes. Two
enzymes, sphingosine kinase 1 (Sphk1) and Sphk2, which catalyze
the ATP-dependent phosphorylation of sphingosine to generate S1P,
are expressed by thymic pericytes that represent non-epithelial cells
ensheathing blood vessels at the sites of T-cell exit.71 The essential
role of thymic pericyte Sphk activity has been demonstrated by stud-
ies utilizing cell-specific deletion of Sphk in thymic pericytes. Such
conditional Sphk deletion resulted in an intrathymic accumulation of
mature thymocytes and an accompanying peripheral T-cell lymphope-
nia, both of which are indicative of disrupted thymocyte egress and
thus highlights the crucial role of thymic mesenchyme in regulating
T-cell egress via the S1P pathway.71 In addition to thymic pericytes,
additional nonepithelial stromal populations have been shown to regu-
late S1P-dependent egress through the positive influence of S1P lev-
els. Fukuhara et al.72 showed that thymic endothelium can regulate
S1P-dependent thymocyte egress through the expression of the S1P
transporter spinster homolog 2 (Spns2). Thus, Spns2 is required for
S1P release from endothelial cells, correspondingly deletion of Spns2
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resulting in intrathymic accumulationofmature thymocytes consistent
with an egress defect.72
Conversely, the maintenance of intrathymic S1P gradients can
occur through the degradation or dephosphorylation of S1P to ensure
low levels at the sites that the mature T-cells migrate from. Such
regulation can operate via the coordinated activity of both stromal
and hematopoietic compartments. An example of stromal regulation
is through the production of lipid phosphate phosphatase 3 (Lpp3),
a dephosphorylating enzyme that inactivates S1P to maintain low
intrathymic S1P levels promoting thymocyte egress.73 Deletion of
Ppa2b, the gene encoding Lpp3, results in an intrathymic accumula-
tion of mature thymocytes consistent with an egress defect. Interest-
ingly deleting Ppa2b specifically on TECs or endothelial cells results
in an equivalent intrathymic accumulation of mature thymocytes and
therefore both TECs and endothelial cells regulate SIP-dependent thy-
mocyte egress through production of Lpp3.73 TECs and endothelial
cells have also been shown to express S1P lyase (Sgpl), an enzyme that
degrades S1P to maintain low levels of S1P to regulate T-cell egress.
However a recent study by Zamora-Pineda et al.74 found that dele-
tion of Sgpl in either TECs or thymic endothelial cells was not suffi-
cient to cause a T-cell egress defect. In fact it was only the deletion
of Sgpl in bone marrow-derived cells that resulted in reduced thymo-
cyte egress and a concomitant intrathymic accumulation of mature
SP thymocytes.74 These bone-marrow derived cells included DCs as
well as T-cells themselves, suggesting additional cell types beyond the
thymic microenvironment that are able to influence thymocyte egress
via the S1P–S1PR1 pathway.74
S1P is generated through the phosphorylation of sphingosinewhich
itself is synthesized from ceramide.75 Ceramide synthase 2 (Cers2) is
a known regulator of sphingosine, acting to limit S1P levels via con-
version of sphingosine into long-chain ceramides.76 Recent studies
have highlighted the essential role of Cers2 in the regulation of thymic
egress. Rieck et al.77 revealed that Cers2-deficientmice demonstrated
an intrathymic accumulation of mature SP thymocytes as well as a
reduction of SP4 and SP8 thymocytes within the blood and spleen.
Further analysis revealed that the intrathymic and blood levels of S1P
were increased and thus T-cell egress was defective due to dysregula-
tion of the S1P gradient, identifying Cers2 as an additional candidate
to a growing list of regulators of S1P-dependent T-cell egress and thus
highlighting the multifaceted aspect of the S1P pathway for thymic
egress.77 Interestingly, the essential activity of Cers2 in the regula-
tionof thymic egresswasattributed tononhematopoietic stromal cells,
potentially includingbloodendothelium.Given thepositioningofblood
endothelial cells as the final cellular barrier between thymic microen-
vironments and the peripheral circulation, it raises the interesting
proposition that blood endothelial cells act as a vital gatekeeper for
thymic emigration.
5 CHEMOKINES
T-cell development in the thymus involves the directed migration
of cells through distinct thymic microenvironments. In relation to
chemokine receptors and SP thymocyte migration, CCR7 plays a key
role in entry of these cells to the medulla via the expression of its lig-
and CCL21 by mTEC.23,43 For thymic egress, CCR7 has been shown
to be dispensable for the exit of mature conventional and Foxp3+ reg-
ulatory 𝛼𝛽T-cells from the adult thymus.23,78 In contrast, a role for
CCR7 in egress from the neonatal thymus is supported by several
observations. For example, Ccr7−/− neonates show an increased fre-
quency of thymocytes and decreased splenic T-cell numbers.79 More-
over, injecting mice with reagents to selectively block either CCL19 or
CCL21 function showed that, blocking CCL19 but not CCL21, resulted
in increased thymocyte numbers and decreased splenic T-cell num-
bers. While these observations are consistent with a role for CCR7–
CCL19 in emigration in the neonatal period, it is important to note
that a recent study analyzing Ccl19−/− mice showed that CCL19 is
required for normal splenic white pulp development, suggesting that
the reduction in splenic T-cell numbers is a direct consequence of
defects in the spleen, and is not secondary to a thymus egress effect.80
Interestingly, and in support of this, no changes in the frequencies
of SP thymocytes were noted in Ccl19−/− neonates, and so the lig-
and requirements for CCR7-mediated emigration from the neonatal
thymus require further examination. However, it is also interesting to
note that additional studies indicate the mechanisms involving CCR7
that control egress from the neonatal and adult thymus may be differ-
ent. For example, neonatal Aire−/− mice, which were reported to have
reduced intrathymic CCR7-ligand expression, also show evidence of
impaired thymocyte egress.81 This study also indicated that while the
thymic S1P–S1PR1 pathway is functional at the neonatal stage, it is
not sufficient to correct for the defect in CCR7-dependent egress.81
However, beyond 3 weeks of age in Aire−/− mice, S1PR1 underwent
significant compensatory upregulation on mature thymocytes, which
alleviated the T-cell egress defect seen in neonatal mice.81 Thus, accu-
mulating evidence indicates that CCR7 may act in concert with other
regulators of thymic egress in a manner that is influenced by neona-
tal/adult time periods.
The chemokine receptor CXCR4 has also been suggested to play
a role in thymus emigration. However, until recently, this has been
difficult to directly examine in vivo due to the embryonic lethality
of mice lacking CXCR4, and its ligand CXCL12.82–85 Consequently,
many experimental approaches that have been used to address the
role of CXCR4 in mature SP thymocyte migration involve in vitro thy-
mus organ cultures and/or the pharmacologic inhibition of CXCR4–
CXCL12 function.83,84 However, using a Cre-mediated stage-specific
approach to delete CXCR4 expression from the DP thymocyte stage,
the role of CXCR4 in thymic emigration was recently analyzed in the
steady state thymus in vivo. Interestingly, analysis of CD4creCXCR4flox
mice found no abnormalities in SP thymocyte development or egress,
suggesting that CXCR4 is dispensable for these processes.86 Impor-
tantly, this lack of requirement for CXCR4 in SP thymocyte migration
also correlatedwith the rapid terminationofCXCR4 following the initi-
ation of positive selection, and the predominant expression of CXCL12
in the thymic cortex and not themedulla.
While the above studies indicate the differential requirement for
certain chemokines in thymic emigration, the cell types that express
these molecules, and the mechanisms that control their production in
thymic stroma, are not fully understood. However, pioneering studies
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by Boehm et al.30 showed that LT𝛽R, a TNFRSF member that regu-
lates chemokine expression in lymphoid tissues plays an essential role
in controlling thymic egress.87,88 Thus, adult Ltbr−/− mice were shown
to have an intrathymic accumulation of mature SP4 and SP8 thymo-
cytes, as well as altered medullary organization andmTEC numbers.30
Whether the requirement for LT𝛽R in thymic egress maps to its abil-
ity to control intrathymic expression of chemokines remains unclear.
Interestingly however, TECs express the CCR7-ligands CCL21 and
CCL19, which are known targets of LT𝛽R signaling, and LT𝛽R-deficient
mice have been showed to have a reduction inCCL21+mTEC.44,87 Rel-
evant to this, as CCR7 is not required for thymus emigration in the
adult, it is perhaps likely that LT𝛽R regulates T-cell egress via mecha-
nisms additional to its control of CCR7 ligand availability.
6 THE TYPE 2 IL-4R AND THYMIC
EMIGRATION
In an attempt to identify novel regulators of thymus emigration, we
examined the thymic architecture of mice carrying deletions in genes
identified as being expressed by TEC via microarray analysis. Specif-
ically, we investigated the intrathymic positioning of mature SP4 and
SP8 thymocytes, and concentrated onmouse strains where the typical
random distribution of these cells within thymic medullary areas was
altered. We saw that in Il4ra−/− mice, the thymus medulla contained
large mTEC-free areas filled with SP thymocytes,89 and the thymus
was enriched in the most mature CD69−CD62L+ SP4 thymocyte sub-
set. Further examination showed these structures to be enlarged PVS
that were surrounding thymic blood vessels. Interestingly, IL-4R𝛼 is a
component of 2 cytokine receptors. Paired with the common gamma
chain, it forms the Type 1 IL-4R complex on lymphocytes with binds
IL-4. In contrast, when IL-4R𝛼 is complexed with IL-13R𝛼1 on stromal
cells, it forms the Type 2 IL-4R complex that binds both IL-4 and IL-13.
mTECs were found to express all Type 2 IL-4R components, and the
intrathymic accumulation of SP thymocytes was found to map to
IL-4R𝛼 expression by thymic stroma. Thus, Type 2 IL-4R expression by
the thymicmicroenvironment represents an important regulator of SP
thymocytes where it acts as a regulator of thymic egress. When exam-
ining whether the role of IL-4R𝛼 in this process was connected to the
known role for the S1P–S1PR1 axis, we found that cell surface levels of
S1PR1 and CD69 onmature thymocytes inWT and Il4ra−/− micewere
comparable, suggesting that intrathymic S1P levels were not substan-
tially altered. Moreover, treatment of both WT and Il4ra−/− mice with
FTY720 resulted in an intrathymic retention of SP thymocytes, indi-
cating that S1PR1-mediated migration remained active in the thymus
of Il4ra−/− mice.While these findings suggest that the requirement for
the Type 2 IL-4R in thymus emigration is distinct to the involvement
of S1P–S1PR1, its mechanism of action is unclear. Relevant to this is
that the thymus accumulation seen in Ltbr−/− mice does not appear
to involve accumulation within thymic PVS, making it perhaps unlikely
that the IL-4R𝛼 axis is directly regulated by LT𝛽R. Interestingly,
triggering Type 2 IL-4R signaling in thymic stroma with either IL-4
or IL-13 induced the expression of a broad array of chemokines
including CCL21, one of the ligands for CCR7 that has been impli-
cated in thymus emigration in the neonate.79 While further work is
required to examine the role of IL-4R𝛼 in thymic egress, its role in this
process was shown to map to the provision of the type 2 cytokines
IL-4 and IL-13 by a thymic-resident subset of CD1d-resctricted
iNKT-cells, providing a cellular mechanism for its action. Finally, that
innate-like iNKT-cells play a role in controlling the emigration of
conventional 𝛼𝛽T-cells from the thymus provides a further example of
how innate-like cells influence thymus function via cellular crosstalk in
themedulla.90
6.1 T-cell intrinsic regulators of T-cell egress
As well as regulation of T-cell egress occurring via T-cell extrinsic reg-
ulation, T-cell intrinsic pathways have been identified that are essen-
tial for T-cell egress. The protein kinase Mst1 forms a complex with
RAPL to activate Mst1 kinase, which regulates lymphocyte polariza-
tion and adhesion stimulated by chemokines and TCR signaling. In
the context of T-cell egress Dong et al.91 showed that MST1 plays
an essential role in regulating T-cell egress. Mst1−/− mice exhibit an
intrathymic accumulation of mature SP thymocytes as well as reduced
lymphocytes both in the blood and peripheral tissues.91 Interestingly
through the use of p56LckcreMst1fl mice, the role of Mst-1 was shown
to be T-cell intrinsic as these mice also had an intrathymic accumula-
tion of mature SP4 and SP8 thymocytes.91 Mst1−/− thymocytes have
impaired chemotactic response to chemokines but not S1P suggesting
the regulation of T-cell egress by Mst1 is S1P-independent, again sug-
gesting that active thymic emigration relies upona fine-tuned interplay
betweenmultiple regulators of T cellmigration.91 The role ofMst2was
also identified through the use of Mst1−/−Mst2−/− double knockout
mice, which exhibited an exacerbated intrathymic accumulation that
was of greater magnitude than the Mst1−/− thymus implicating Mst2,
as well asMst1, in regulating T-cell egress.92
The actin regulator Coronin-1A (Coro1a) has additionally been
shown to be essential for normal thymic egress. The mouse strain
Cataract Shionogi (CTS) was initially reported to have a T-cell egress
defect, exhibiting an intrathymic accumulation of SP thymocytes
within the perivascular space and reduced RTE in the periphery.93
It was later found that the CTS strain phenotype was caused by a
pointmutation in the gene encoding Coro1a.94 Interestinglymice defi-
cient for Coro1a have a reduction in peripheral T-cells however this
phenotype is also accompanied by an intrathymic loss of mature SP
thymocytes due to impaired survival and thus investigation of the
importance of Coro1a is complicated by this phenotype. However
the CTS strain which carries the peripheral T-cell deficiency (Ptcd)
locus and thus have the point mutation in the Coro1a gene displayed
normal cell survival of mature thymocytes and subsequently this
revealed a block in T-cell egress as measured by an intrathymic accu-
mulation of mature SP thymocytes as well as the reduction of SP
thymocytes within the periphery.93,94 Surprisingly, despite these SP
thymocytes expressing normal S1PR1, their ability to migrate toward
S1P, as well as other chemokines, was significantly impaired due to
defective actin remodelling.94 This intrathymic accumulation in the
absence of impaired cell survival as well as the inability to migrate
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toward S1P and chemokines such as CCL21 highlights a key role of
Coro1a in regulating T-cell thymic egress.
7 CONCLUDING REMARKS
The regulation of thymus-dependent 𝛼𝛽T-cell maturation concludes
with the release of those mature, functionally self-tolerant T-cells that
have survived the rigors of intrathymic selection events into the sys-
temic circulatory system. Notably the development of thymocytes fol-
lows a strictly controlled pathway of maturational hurdles sequen-
tially characterised by thymus entry and T-cell specification, posi-
tive selection, central tolerance enforcement and finally acquisition of
egress competency. The developmental transition of T-cells along this
course is dictatedvia the coordinatedmigrationof thymocytes through
highly specialized subcompartmentsof the thymusdefinedbyadiverse
mixture of both hematopoietic and stromal cell types. Despite the
importance of this process to the generation of a sufficiently
diverse repertoire of 𝛼𝛽T-cells capable of providing protection against
pathogenic challenge and tumor formation, the precise cellular
and molecular pathways that dictate this process remain incom-
pletely understood. For instance, although several G-protein cou-
pled receptor-associated pathways, including both chemokine and S1P
interactions have been implicated in the regulation of thymic emigra-
tion, the combinatorial effect of such pathways remains unclear. In
particular determining the precise balance of those signals that act
to retain thymocytes within the thymic medulla to ensure sufficient
screening of T-cells for self-reactivity versus those that positively drive
thymic egress will be critical to advance our understanding of how the
pressures of constantly replenishing the peripheral T-cell repertoire
are balanced against the need to ensure self-tolerance via medullary
dwell-time. Moreover, whilst it is important to understand how these
processes operate in the steady state, how the balance of intrathymic
T-cell retention and egress may be altered following acquired periph-
eral T cell lymphopenia and the impact that this may have on central
tolerance raises important questions. In summary, whilst the mech-
anisms regulating thymic 𝛼𝛽T-cell maturation and emigration have
begun to be unraveled, furtherwork defining these processeswill have
important implications for the future development of routes tomanip-
ulate T-cell tolerance and seeding of the peripheral T-cell pool.
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